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Abstract
Introduction: Despite improvements in surgical management, ster-
nal wound infection (SWI) following cardiac surgery remains a sig-
nificant complication.
Aim: To evaluate pathogens involved in SWI following median ster-
notomy.
Material and methods: We enrolled 164 patients who experienced 
prolonged sternal wound healing following open-heart surgery. The 
inclusion criteria were as follows: prolonged sternal wound heal-
ing following cardiac surgery via median sternotomy and complete 
results of microbiological culture obtained from the sternal swab. 
The exclusion criteria were as follows: partial sternotomy, patients 
with mechanical sternum dehiscence and incomplete clinical data. 
Swabs provided information on the type of microorganism pres-
ent in the wound and the susceptibility of the microorganism to 
specific antibiotics. 
Results: One hundred and fourteen (69.5%) patients aged 68 (inter-
quartile range: 60–76) years developed SWI with positive culture. 
The in-hospital mortality rate was 21.0% in this group. The most 
common pathogens included Staphylococcus epidermidis (26.6%), 
Enterococcus faecium (12.2%), Staphylococcus aureus (11.4%), Kleb-
siella pneumoniae (8.4%), and Pseudomonas aeruginosa (6.8%). 
In most of the cases the isolated Staphylococcus epidermidis was 
methicillin-resistant (n = 57, 43.5%). Enterococcus faecium was van-
comycin-resistant in 11 (8.3%) cases and high-level aminoglycoside 
resistant (HLAR) in 13 (9.9%) cases. Klebsiella pneumoniae had the 
extended-spectrum β-lactamase (ESBL) mechanism in 14 (10.6%) 
cases. Among 114 culture-positive patients, 48 (42.1%) had polymi-
crobial infection of the sternal wound.
Conclusions: Microorganisms associated with SWI in our study 
were mainly commensals, with the most common pathogen being 
Staphylococcus epidermidis.
Key words: sternal wound infection, cardiac surgery.
Streszczenie
Wstęp: Pomimo udoskonaleń w procedurach chirurgicznych nadal 
głównym powikłaniem po operacjach kardiochirurgicznych są za-
każenia ran mostka.
Cel: Ocena patogenów, które wywołują zakażenia ran mostka po 
sternotomii pośrodkowej.
Materiał i metody: Do badania włączono 164 pacjentów, u których 
stwierdzono przedłużone gojenie rany mostka po operacji kardio-
chirurgicznej. Kryteria włączenia stanowiły przedłużone gojenie się 
rany mostka po operacji kardiochirurgicznej z dostępu przez ster-
notomię pośrodkową i kompletne wyniki hodowli mikrobiologicz-
nej uzyskane z wymazu z mostka, natomiast kryteria wyłączenia 
– częściowa sternotomia, mechaniczne rozejście się mostka i nie-
kompletne dane kliniczne. Mikroorganizmy były identyfikowane za 
pomocą hodowli mikrobiologicznej, na podstawie której określano 
także ich lekowrażliwość. 
Wyniki: U 114 (69,5%) pacjentów w wieku 68 lat (rozstęp między-
kwartylowy: 60–76) doszło do zakażenia rany mostka. Śmiertel-
ność w tej grupie wynosiła 21%. Najczęściej izolowane patogeny 
to: Staphylococcus epidermidis (26,6%), Enterococcus faecium 
(12,2%), Staphylococcus aureus (11,4%), Klebsiella pneumoniae 
(8,4%), Pseudomonas aeruginosa (6,8%). Większość wyizolowa-
nych szczepów Staphylococcus epidermidis była metycylinoopor-
na – 57 (43,5%). Enterococcus faecium był oporny na glikopeptydy 
w 11 (8,3%) przypadkach oraz na duże stężenia antybiotyków 
aminoglikozydowych w 13 (9,9%) przypadkach. Klebsiella pneu-
moniae wytwarzała β-laktamazy o rozszerzonym spektrum sub-
stratowym (ESBL) w 14 (10,6%) przypadkach. Spośród 114 pacjen-
tów z dodatnim wynikiem posiewu w 48 (42,1%) przypadkach 
odnotowano infekcje wielopatogenowe.
Wnioski: Mikroorganizmy powodujące wyżej wymienione za-
każenia to głównie komensale, a najczęściej występującym 
patogenem był Staphylococcus epidermidis.
Słowa kluczowe: zakażenia ran mostka, operacja kardiochi-
rurgiczna. 
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Introduction
Patients undergoing cardiac surgical procedures using 
sternotomy have significant risk of sternal wound infection 
(SWI). Superficial sternal wound infection (SSWI), which 
involves the skin, subcutaneous tissue and the pectoralis 
fascia, has an incidence of 0.5% to 8%, with an associat-
ed morbidity and mortality rate ranging from 0.5% to 9% 
[1, 2]. Superficial sternal wound infection are often com-
pletely eradicated with intravenous antibiotics and local 
wound care. The incidence of deep sternal wound infec-
tion (DSWI), despite advances in prevention, still remains 
significant, and ranges between 0.5% and 6.8% [3–5], with 
in-hospital mortality rates between 7% and 47% [3–5]. In 
many cases, traditional markers of infection such as fever, 
leucocytosis and C-reactive protein (CRP) have proved un-
reliable [6]. Some patients require further surgery, including 
repeated debridement and major surgical reconstruction. 
It has been reported that there are several risk factors of 
DSWI, including obesity, chronic obstructive pulmonary dis-
ease (COPD), prolonged ventilation, previous cardiac sur-
gery, diabetes mellitus (DM), re-exploration for bleeding, 
age, length of stay, reperfusion syndrome, type of proce-
dure (coronary artery bypass graft surgery (CABG) or valve 
replacement/repair (VR)), type of admission to hospital, 
type of discharge, postoperative blood transfusion, and os-
teoporosis [1, 7–9]. 
After surgery, many wounds are infected with the en-
dogenous patient pathogens. Deep sternal wound infection 
usually present with systemic signs of infection or local 
signs, such as chest pain and wound discharge [10]. Swabs, 
or preferably pus, obtained directly from the wound or ab-
scess, are recommended to identify the causative patho-
gen. Commonly occurring microorganisms responsible for 
hospital wound infection are Staphylococcus aureus, Strep-
tococcus pyogenes, Escherichia coli, Proteus spp., anaerobes, 
Enterococcus spp. and coagulase-negative staphylococci 
(CoNS) [11]. Recent reports have shown a growing number 
of DSWI caused by methicillin-resistant (MR) Gram-positive 
pathogens, especially Staphylococcus epidermidis, which is 
one of the most common bacteria in post-sternotomy me-
diastinitis, and about 75% of strains are MR [4]. 
Surveillance data for surgical site infection (SSI) from 
16 countries that comprised 422,201 surgical operations 
from 1,332 hospitals published in 2012 showed that the 
most common pathogens identified in wounds following 
CABG are Gram-positive cocci (60.3%) (Staphylococcus au-
reus – 26.7%), CoNS (24.6%) and Gram-negative bacilli En-
terobacteriaceae (23.0%) [12].
The interpretation of bacteriological findings still de-
pends on the quality of the specimens analysed and could 
be challenging [13].
The treatment of DSWI poses major problems lead-
ing to high mortality and poor outcomes of conventional 
wound management techniques and new approaches to 
therapy. The standard medical treatment for DSWI includes 
antibiotics, surgical debridement, re-suturing and negative 
pressure wound therapy (NPWT). Debridement followed by 
the placement of a wound vacuum-assisted closure (VAC) 
is a commonly used and effective DSWI treatment in recent 
years [10]. The VAC therapy system replaced most of the 
conventional types of wound treatment due to the faster 
wound healing, shorter length of hospital stay and lower 
in-hospital cost. The currently available data suggest a low-
er mortality rate and support the use of VAC therapy for 
treatment of patients with DSWI following cardiac surgery, 
but the effect of VAC on the length of stay (LOS) and the 
cost should be further investigated [14]. In some cases, the 
use of hyperbaric oxygen therapy (HBO2) in patients with 
DSWI after surgery might be helpful to cure the infection. 
Litwinowicz et al. [3] showed that HBO2 as an additional 
therapy in DSWI was successful in 80% of cases. 
Aim
The aim of the study was to evaluate pathogens in-
volved in SWI following median sternotomy.
Material and methods
Between 1st January 2016 and 31st May 2017, 2986 opera-
tions were performed at the Department of Cardiovascular 
Surgery and Transplantology, the John Paul II Hospital, Krakow, 
Poland. In this retrospective study, we enrolled 164 patients 
aged ≥ 18 years. The inclusion criteria were as follows: a pro-
longed sternal wound healing following cardiac surgery via 
median sternotomy and complete results of microbiological 
culture obtained from the sternal swab. The exclusion criteria 
were as follows: partial sternotomy, patients with mechanical 
sternum dehiscence and incomplete clinical data. All postop-
erative sternal wound complications were referred back to our 
department from other hospitals and rehabilitation facilities. 
All patients who underwent surgery in the study period were 
screened. The total number of patients included in this study 
was 164. We divided the patients into two groups, based on 
the culture results: the SWI group (pathogen identified) and 
a negative culture group.
Data on demographics, comorbidities, type of hospital 
admission (elective, urgent or emergency), risk factors and 
causative pathogens, and therapeutic modes, in particular 
antibiotic treatment, drainage system, VAC, and gentami-
cin-collagen sponge use, were collected based on medical 
records. Antibiotics are not routinely prescribed for home 
use or prescribed at discharge from our department. Only 
patients with confirmed or suspected infection continue 
treatment after discharge.
Standardized anaesthetic and surgical procedures were 
applied in all cases. Perioperative antibiotic prophylaxis 
comprised cefazolin 4 × 2 g i.v. within 24 h (the first dose 
preoperatively, infusion being completed 60–30 min be-
fore skin incision); if the operation was prolonged, another 
dose was added to the cardiopulmonary bypass (CPB). In 
patients with documented b-lactam allergies, clindamycin 
was given 3 × 600 mg i.v. within 24 h, following the same 
protocol. Individuals with documented methicillin-resistant 
Staphylococcus aureus (MRSA) colonization received van-
comycin 2 × 1g i.v. (the pre-operative infusion of 1 h dura-
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tion had to be completed at least 60 min preoperatively). 
Skin preparation included pre-operative bathing with soap 
and hair removal by means of clipping. In the operating 
room, directly before the onset of the surgical procedure, 
the skin preparation was performed 4 times (once in the 
anaesthesia preparation room, and 3 times in the oper-
ating room before draping) using the coloured antiseptic 
solution (Kodan Tinktur forte coloured, Schülke & Mayr, 
Norderstedt, Germany). Draping followed no sooner than 
3 min after the last skin preparation. All patients underwent 
an operation through a full or mini-sternotomy, with CPB, 
which was performed in hypothermia according to the sur-
geons’ preference (oesophageal temperature, 28–34°C) us-
ing a non-pulsatile roller pump and a 40 μm arterial blood 
filter (both, Jostra Medizintechnik AG, Hirrlingen, Germa-
ny), with blood flow of 2.0–2.4 l/min/m2 and mean arterial 
pressure of 40–60 mm Hg. Diabetic patients, or those at 
high risk of infection, as assessed by the surgeon, received 
a gentamycin-collagen sponge (Garamycin, EUSA Pharma, 
Hemel Hempstead, UK). All patients were transferred to the 
intensive care unit for postoperative ventilation, and were 
extubated following the standard criteria. 
The diagnosis of wound infection was confirmed by 
the positive bacterial culture results. Wound swabs were 
collected and empiric antibiotic therapy was indicated. Be-
fore the swab from the wound was collected, the wound 
edges were disinfected with alcohol or disinfectant. The 
material was taken from the border and the central part of 
the wound, trying to erase about 1 cm2. From deep wounds 
the material was collected by puncture with a needle and 
syringe. Aspirated material was introduced into the trans-
port medium, and after being properly sealed it was trans-
ported to the laboratory in special thermostatic transport 
containers within 2 h. The pathogens were grown on the 
prepared selective culture media: MacConkey agar and Co-
lumbia agar with 5% sheep blood (bioMérieux, France) at 
35–37°C for 18–24 h according to the local procedures. Ad-
ditionally, chromogenic medium for selective isolation and 
direct identification of Staphylococcus aureus was used 
(CHROMID Staphylococcus aureus Elite agar – SAIDE; bio-
Mérieux, Marcy l’Etoile, France). Sabouraud agar medium 
(bioMérieux, Marcy l’Etoile, France) was used for detection 
of fungal infection, incubated at 35–37°C for 7 days. The 
VITEK 2 Compact (bioMérieux, Marcy l’Etoile, France) au-
tomated identification system was used for determination 
of the antibiotic susceptibility, according to the clinical and 
laboratory standards. The susceptibility profile of the or-
ganism cultured from the sternal wound was sent back to 
the managing physician. In 114 cases culture reports and 
antibiotic susceptibility tests showed bacterial or bacterial-
fungal flora. Targeted antibiotic therapy was performed 
based on the microbiology results and was carried out in 
cooperation with the hospital infection team. 
Statistical analysis
Statistica version 13.0 (StatSoft) was used for statistical 
analysis. Categorical variables were expressed as numbers 
and percentages, while other data were presented as me-
dian and interquartile range. The Shapiro-Wilk test to as-
sess the normality of the variable distribution. Differences 
between nominal variables were analysed with the c2 test. 
The non-parametric Mann-Whitney U test was used for 
further analysis due to the non-normal distribution of con-
tinuous variables. A p-value less than 0.05 was considered 
significant. 
Results
A total 164 patients were clinically diagnosed with pro-
longed wound healing (Table I), and were included in the 
final analysis, including 114 (69.5%) patients with a posi-
tive culture from a sternal wound and 50 (30.5%) patients 
with a negative culture, who served as a negative culture 
group. In both groups, there were patients who experi-
enced prolonged sternal wound healing. The majority of 
patients were men (n = 128, 78%), aged over 50 years. Pa-
tients had various comorbidities, including COPD (n = 24, 
14.6%), DM (n = 64, 39.0%), chronic kidney disease (CKD) 
(n = 34, 20.7%), malignancy (n = 8, 4.9%), and obesity 
(n = 67, 40.8%) (Table I). There were 75 (45.7%) patients 
following CABG, 51 (31.1%) patients following VR, 18 (11.0%) 
patients following CABG combined with VR, and 5 (3.1%) 
patients following aortic aneurysm treatment. At the index 
procedure, 61 (37.2%) subjects received a gentamicin-colla-
gen sponge. All of the patients were treated with antibiot-
ics upon diagnosis of prolonged wound healing (initiated 
upon swab collection), while 59 (36.0%) patients were ad-
ditionally treated with the drainage system, and 68 (41.4%) 
individuals underwent the VAC therapy. One (0.6%) patient 
underwent additional HBO2 treatment.
Hyperbaric oxygen management
The patient who underwent HBO2 treatment was 
a 75-year-old man, with DM, after aortic and mitral valve 
replacements. He was admitted back to hospital after 
1898 days post-procedurally, with the symptoms of SWI. 
Polymicrobial infection was observed, and the identified 
pathogens included MR Staphylococcus epidermidis, MR 
Staphylococcus haemolyticus, Pseudomonas aeruginosa 
and Serratia marcescens. After several revisions of the ster-
nal wound due to impaired healing, usage of VAC and tar-
geted antibiotic therapy, the decision was made to start 
the treatment in the hyperbaric chamber, with a good out-
come. The patient was discharged in good condition with 
the wound healed.
Comparison of patients with and without 
positive wound cultures
There were no differences between the SWI group and 
the negative culture group with respect to age, sex, comor-
bidities, time since the index procedures, smoking status, 
American Society of Anaesthesiologists (ASA) score, or type 
and duration of surgery (Table I). There was a significant 
difference in the VAC treatment between the groups: in the 
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SWI group VAC was used more than 4 times as frequently 
compared to the negative culture group (62 (54.4%) vs. 
6 (12.0%), p < 0.001). Patients from the SWI group had 
mean hospital length of stay (LOS) of 35.5 days vs. 20.5 
days in the remainder (p = 0.01). Death before discharge 
occurred in 29 (17.7%) cases in both groups: 5 (3%) patients 
in the negative culture group and 24 (14.6%) patients in the 
SWI group.
Identified pathogens
The most common pathogens in order of decreasing 
prevalence included Staphylococcus epidermidis (26.6%), En-
terococcus faecium (12.2%), Staphylococcus aureus (11.4%), 
Klebsiella pneumoniae (8.4%), and Pseudomonas aerugino-
sa (6.8%). The spectrum of causative pathogens is shown 
in Figure 1. In most of the cases isolated Staphylococcus 
epidermidis was MR, n = 57 (43.5%) (Table II). Enterococ-
Table I. Baseline characteristics of study groups
VVariable Total
(n = 164)
Negative culture 
group
n = 50 (30.5%)
SWI group
n = 114 (69.5%)
P-value
Age, median (IQR) [years] 66.5 (59–75) 68.0 (60–76) 0.55
Male sex, n (%) 128 (78.0) 42 (84.0) 86 (75.4) 0.22
Type of hospital admission: planned admission, n (%) 86 (52.4) 20 (40.0) 66 (57.9) 0.002
Time since the index procedure, median (IQR) [days] 20 (7–42) 21 (12–39) 0.69
Hospital stay, median (IQR) [days] 20.5 (8–56) 35.5 (19–54) 0.012
Current smokers, n (%) 19.0 (12.3) 8 (16.7) 11 (10.4) 0.27
Surgical procedure:
CABG, n (%) 75 (45.7) 19 (38.0) 56 (34.2) 0.64
Valve replacement/repair isolated, n (%) 51 (31.1) 16 (32.0) 35 (30.7) 0.87
CABG and valve replacement/repair combined, n (%) 18 (11.0) 6 (12.0) 12 (10.5) 0.78
Aortic aneurysm, n (%) 5 (3.1) 2 (4.0) 3 (2.6) 0.64
LVAD, n (%) 3 (1.8) 3 (6.0) 0 (0.0) 0.008
Other procedures*, n (%) 12 (7.3) 4 (8.0) 8 (7.0) 0.82
Non-clean operation, n (%) 3 (2.0) 1 (2.3) 2 (1.9) 0.87
ASA score, n (%) III; IV; V 11 (25.6); 30 (69.8); 2 (4.7) 38 (36.2); 62 (59); 5 (4.8) 0.45
Duration of operation [min] 275 (220–330) 270 (225–330) 0.88
Therapy used, n (%):
Vacuum-assisted closure 68 (41.4) 6 (12.0) 62 (54.4) < 0.001
Gentamicin-collagen sponge 61 (37.2) 15 (30.0) 46 (40.4) 0.21
Drainage system 59 (36.0) 18 (36.0) 41 (36.0) 0.99
Comorbidities, n (%):
Cardiovascular disease 155 (94.5) 50 (100) 105 (92.1) 0.041
Chronic obstructive pulmonary disease              24 (14.6) 4 (8.0) 20 (17.5) 0.11
Diabetes mellitus 64 (39.0) 19 (39.6) 45 (42.5) 0.74
Chronic kidney disease 34 (20.7) 9 (18.0) 25 (22.0) 0.57
Malignancy 8 (4.9) 3 (6.0) 5 (4.4) 0.66
Obesity 67 (40.8) 18 (37.5) 49 (46.2) 0.32
Alcoholism 5 (3.0) 2 (4.2) 3 (2.8) 0.66
Survival 135 (82) 45 (90) 90 (79) 0.09
Data are presented as number (percentage) for categorical variables, or as median (interquartile range (IQR)) for continuous variables. CABG – coronary artery 
bypass graft surgery, LVAD – left ventricular assist device, ASA – American Society of Anaesthesiologists (ASA) score, *other procedures included: pericardiectomy, 
cardiac tumour removal, pericardiocentesis, cardiac tamponade.
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cus faecium was vancomycin-resistant in 11 (8.3%) cases 
and high-level aminoglycoside resistant (HLAR) in 13 (9.9%) 
cases. Klebsiella pneumoniae had the extended-spectrum 
β-lactamases (ESBL) mechanism in 14 (10.6%) cases. The 
mechanisms of antimicrobial resistance in bacteria are pre-
sented in Table II. 
Polymicrobial infections
Among 114 culture-positive patients, 48 (42.1%) had 
polymicrobial infection of the sternal wound. The risk 
of polymicrobial SWI was increased with obesity (OR = 
3.17, 95% CI: 1.39–7.21, p = 0.005), longer LOS (OR = 1.03, 
95% CI: 1.01–1.05, p = 0.0002), and DM (OR = 3.52, 
95% CI: 1.53–8.05, p = 0.003). Smoking, alcoholism and age 
had no significant effect on the occurrence of polymicrobial 
infection.
Polymicrobial infection with  
pandrug-resistant (PDR) Klebsiella 
pneumoniae
One case of polymicrobial infection followed by an in-
fection with PDR Klebsiella pneumoniae was a 62-year-old 
obese woman with acute coronary syndrome, who under-
went urgent CABG in our hospital. She was preoperatively 
diagnosed with hypertension, severe COPD, DM on insulin 
and CKD. The surgery and early postoperative course were 
uneventful, and the patient was discharged on day 7 post-
operatively to the rehabilitation facility. About 10 days after 
the surgery, the patient complained of sternal pain, puru-
lent discharge, and sternal instability, but remained afe-
brile. She was re-admitted, and Enterococcus faecalis was 
found in the wound swab. Antibiotic therapy was initiated. 
The VAC system was used and additional material from the 
wound was sent to the laboratory, where two microorgan-
isms were identified: MR Staphylococcus epidermidis and 
Staphylococcus haemolyticus. Additionally, 3 days after the 
specimen was obtained, Klebsiella pneumoniae with the 
ESBL mechanism was revealed. After several VAC dress-
ing changes, the sternum was closed, and wound drain-
age was started with Microdacyn 60 Wound Care (Sonoma 
Table II. The most common pathogens isolated from the sternal wounds of 114 cardiac patients and their mechanisms of antimicrobial 
resistance
Causative pathogens Mechanisms of antimicrobial resistance in bacteria, n (%)
MR MS ESBL VRE HLAR XDR MDR None Negative
Staphylococcus epidermidis 57 (43.5) 3 (2.2) 1 (0.7) 70 (53.4)
Enterococcus faecium 11 (8.3) 13 (9.9) 6 (4.5) 101 (77.0)
Staphylococcus aureus 4 (3.0) 17 (12.9) 1 (0.7) 109 (83.2)
Klebsiella pneumoniae 14 (10.6) 5 (3.8) 112 (85.4)
Pseudomonas aeruginosa 2 (1.5) 3 (2.2) 12 (9.1) 114 (87.0)
Staphylococcus hominis 12 (9.1) 119 (90.8)
Staphylococcus haemolyticus 9 (6.8) 122 (93.1)
Enterobacter cloacae 5 (3.8) 5 (3.8) 121 (92.3)
Enterococcus faecalis 1 (0.7) 5 (3.8) 2 (1.5) 123 (93.8)
Proteus mirabilis 1 (0.7) 4 (3.0) 126 (96.1)
MR – methicillin-resistant, MS – methicillin-sensitive, ESBL – extended-spectrum b-lactamases, VRE – vancomycin-resistant Enterococcus, HLAR – high-level 
aminoglycoside resistance, XDR – extensively drug-resistant, MDR – multidrug-resistant. Data are presented as n (%) unless indicated otherwise. None – without 
a resistance mechanism. This group accounted for 84.8% of all pathogens found in sternal wounds.
Fig. 1. Frequency of all causative pathogens isolated in the patients 
with the SWI.*Other bacteria and fungi: Acinetobacter baumannii, 
Candida albicans, Escherichia coli, Serratia marcescens, Morganella 
morganii, Gemella morbillorum, Listeria monocytogenes, Klebsiella 
oxytoca, Citrobacter freundii, Granulicatella elegans
S. epidermidis
 26.6%
Other bacteria 15.2%
Proteus mirabilis 
2.5%
Enterococcus 
faecalis 3.4%
Enterobacter 
cloacae 4.2%
S. haemolyticus 
4.6%
Enterococcus 
faecium 
12.2%
S. aureus 11.4%
Klebsiella pneumoniae 8.4%
P. aeruginosa 6.8%
S. hominis 4.6%
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Pharmaceuticals, Petaluma, CA, USA); however, the wound 
still presented signs of infection and purulent exudate was 
noted. Another wound swab was collected and found to be 
positive for Enterococcus faecium with HLAR, vancomycin-
resistant Enterococcus and Candida albicans. During fur-
ther management the patient became febrile (39°C), and 
extensive blood cultures were collected, which were posi-
tive for Candida parapsilosis. The patient was transferred to 
the ICU, where medical, antimicrobial and antifungal man-
agement followed. After another 3 weeks, the blood cul-
ture revealed PDR and ESBL Klebsiella pneumoniae, the first 
case in our institution with PDR Klebsiella pneumoniae, as 
non-susceptible to all agents in all antimicrobial categories. 
The patient received multidrug antibiotic therapy (linezolid, 
vancomycin, meropenem, colistin, tobramycin, piperacillin-
tazobactam), and stayed in the ICU for 77 days. Afterwards, 
she was transferred to the local hospital for further man-
agement. She was unconscious and intubated, but haemo-
dynamically stable on the day of her transfer. 
Clostridial diarrhoea
Among 164 patients who were included in this study, 
38 (23.1%) were tested for Clostridium difficile toxins 
A/B and an antigen test (C. DIFF QUIK CHEK COMPLETE; 
TechLab/Wampole, Alere, USA); 8 (4.8%) were positive for 
glutamate dehydrogenase (GDH) and toxins A/B, 5 (3.0%) 
patients had positive GDH but negative results for toxin 
A/B, and 25 (15.2%) were negative for both parameters. 
Discussion 
This study documents that Staphylococcus epidermidis, 
Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae and Pseudomonas aeruginosa are the most 
common SWI causative organisms following cardiac sur-
gery. We report that obesity and DM, along with extended 
LOS, increase the chance of polymicrobial wound infection.
Several studies have evaluated the pathogen spectrum 
in SWI patients after heart operations. Chaudhuri et al. [15] 
showed that Staphylococcus aureus was the commonest 
organism cultured from deep sternal tissue (39%), in their 
study performed between 2005 and 2011. Half of the cul-
tured organisms were methicillin-susceptible, followed by 
CoNS (27%), while Gram-negative organisms were cultured 
in less than a quarter of patients (23%). Pseudomonas 
aeruginosa was the most common Gram-negative organ-
ism isolated across samples (6%). None of the Gram-neg-
ative organisms identified possessed extended-spectrum 
b-lactamases [15]. The pathogen spectrum in SWI may dif-
fer between hospitals; for example, in our hospital Staphy-
lococcus epidermidis was the main causative pathogen 
of infection, 26.6% during the study period (Fig. 1). In 57 
(43.5%) cases Staphylococcus epidermidis was MR. Moini-
poor et al. [16] in their study had 82 (1.7%) cases of DSWI, 
with mortality rates in patients with and without infection 
of 10.9% and 6.7%. The causative organisms were Klebsi-
ella, Pseudomonas, CoNS, Acinetobacter, Staphylococcus 
aureus, Escherichia coli, and MR Staphylococcus aureus [16]. 
Klebsiella was the most common isolated pathogen, which 
can be attributed to the lack of routine prophylactic anti-
biotics for Gram-negative coverage in high-risk patients in 
this institution [16]. The mortality rates in individuals with 
and without infection were 14.6% and 3.0% in our hospi-
tal. Additionally, in our institution perioperative antibiotic 
prophylaxis consisting of cefazolin was used. In our study, 
Klebsiella pneumoniae accounted for 8.4% of all infections, 
in 14 cases with the ESBL mechanism. The knowledge of 
pathogens existing in hospitals might help to protect pa-
tients against them by the application of prophylaxis. The 
correctly tailored empirical antimicrobial therapy may help 
to reduce infections.
The different types of SSI are persistent and prevent-
able health care-associated infections. Before surgery, pa-
tients should shower with soap or an antiseptic agent, an-
timicrobial prophylaxis should be administered only when 
indicated, skin preparation in the operating room should 
be performed using an alcohol-based agent, and glycaemic 
control should be implemented [17]. The number of surgi-
cal procedures performed worldwide continues to rise, and 
patients who undergo surgical procedures are getting older 
and have additionally different underlying conditions (ASA 
scores of III, IV and even V are frequent, especially among 
cardiac patients) [18]. In our study, 62 (59) patients from the 
SWI group were assigned an ASA score of IV. One percent of 
patients who have median sternotomy develop SSWI usu-
ally 7–9 days after the operation [6]. In our study, 2.4% the 
patients developed SSWI usually 7–9 days post-operatively. 
DSWI usually presents 2–4 weeks after an operation, but 
can present months or years later [6]. Among the 164 pa-
tients enrolled in this study, 107 (65.2%) developed DSWI. 
Symptoms occurred on average 21 (12–39) days after the 
index procedure. Incidence of SWI as a complication of ma-
jor cardiac surgery was estimated to be around 3.5% in our 
study. Our incidence of SWI was consistent with the results 
of published literature.
Porubnicova et al. [8] identified that polymicrobial DSWI 
were more frequent in older patients, patients with the 
duration of extracorporeal circulation exceeding 120 min, 
longer postoperative hospital stay, in patients readmitted 
from another hospital after initial discharge and in obese 
patients. Microorganisms that colonize the damaged tis-
sues often form polymicrobial communities called biofilms. 
This structure protects them from the host immune system 
and gives them resistance to antibiotic treatment [19]. In 
our study, 48 (42.1%) patients from the SWI group had poly-
microbial infections. Among patients with SWI was 1 wom-
an with polymicrobial infection who additionally developed 
a blood infection and had a positive blood culture for PDR 
Klebsiella pneumoniae. It was the first case in our hospital. 
The wound was successfully healed and the patient was 
transferred to the local hospital for further management.
Cardiac patients differ from those undergoing non-
cardiac surgery in the use of cardiopulmonary bypass and 
systemic hypothermia, the relatively long operating times, 
and the frequent use of central venous access and indwell-
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ing catheters. These differences may encourage the use 
of prophylactic antibiotics for an extended period of time. 
Unfortunately, prolonged antibiotic use > 48 h fails to im-
prove SSI rates, but increases antimicrobial resistance and 
the development of Clostridium difficile disease [20]. In our 
study, 8 (4.8%) patients were positive for GDH and toxins 
A/B. Clostridial diarrhoea during antibiotic treatment for 
SWI is a serious complication, making the management of 
the initial clinical problem more difficult. Toxic megacolon 
associated Clostridium difficile colitis may be lethal in a pa-
tient with SWI following cardiac surgery. 
It is of utmost importance to follow aseptic techniques 
strictly, use appropriate prophylactic antibiotics, and diag-
nose any infection early to decrease the incidence of SWI in 
the future. The knowledge of patient-related risk factors is 
important for choosing the appropriate empirical antibiotic 
therapy. Further studies are therefore necessary to deter-
mine the other SWI risk factors for patients who undergo 
cardiac surgery.
The data were obtained from medical records, which is 
an inherent limitation of retrospective studies. Secondly, 
only the swabs collected from the sternal wounds were 
taken into consideration. Patients were examined for signs 
of infection at the site of surgical incision on presentation 
to the ward, daily during the whole stay and on the dis-
charge day, but by different nurses and doctors. Antibiotics 
used after discharge from hospital were not analysed in 
this study.
Conclusions 
Sternal wound infection are common among patients 
with prolonged wound healing after cardiac surgery. Micro-
organisms associated with SWI in our study were mainly 
commensals, with the most common pathogen being 
Staphylococcus epidermidis.
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